Care pathways in atopic dermatitis: a retrospective population-based cohort study.

Area of Science:

• Dermatology
• Real-world evidence
• Healthcare research

Background:

• Atopic dermatitis (AD) presents with variable severity and healthcare needs.
• Longitudinal patient data analysis offers insights into real-world clinical care, healthcare access, and treatment patterns for AD.
• Understanding patient care pathways is crucial for optimizing management strategies.

Purpose of the Study:

• To describe longitudinal care pathways for patients with atopic dermatitis (AD).
• To analyze healthcare management, treatment patterns, and disease progression proxies in AD patients.
• To evaluate real-world clinical practice in managing AD.

Main Methods:

• A longitudinal observational study utilizing linked national and regional healthcare registers in Sweden.
• Identification of AD patients through diagnosis or dispensed medications.
• Calculation of healthcare visits, drug classes, referral rates, and treatment escalation.

Main Results:

• Over 341,000 patients (pediatric, adolescent, adult) with AD were included.
• Healthcare visits and AD-indicated treatments peaked in the initial year of managed care.
• Topical corticosteroids and emollients were common; systemic treatment was rare. 18.2% escalated to higher potency topical corticosteroids.

Conclusions:

• Healthcare utilization and treatment for AD concentrate in the first year of managed care and decline thereafter.
• Findings suggest potential under-monitoring and undertreatment of AD patients, especially those with persistent or severe disease.
• There is a need for enhanced practitioner education on adequate treatment options for individualized AD care, particularly for severe cases.